Company
Cheplapharm
Last checked: Nov 19, 2026Source: Drugs@FDA, ClinicalTrials.gov
NDAs and BLAs
15
11 still marketed
Novel approvals
6
Approvals since 2021
9
Originals and new uses
Phase 3 trials
0
Registered, any status
Trials by phase
All registered drug and biologic trials with this lead sponsor, any status. A public view of the pipeline.
Recent approvals
Originals and efficacy supplements, newest first.
Drugs in development (0)
Investigational drugs, not yet FDA-approved, in this company's active or recent Phase 2 and 3 trials. Phase 3 first.
No investigational drugs in Phase 2 or 3 trials under this sponsor name.
Recruiting Phase 3 trials
Largest first.
No recruiting Phase 3 trials under this sponsor name.
Marketed drugs (11)
Newest FDA action first.
- Xenical Orlistat · 1999
- Zyprexa Olanzapine · 1996
- Etopophos Preservative Free Etoposide Phosphate · 1996
- Zyprexa Relprevv Olanzapine Pamoate · 2009
- Zyprexa Olanzapine · 2004
- Zyprexa Zydis Olanzapine · 2000
- Seroquel Quetiapine Fumarate · 1997
- Seroquel Xr Quetiapine Fumarate · 2007
- Klonopin Clonazepam · 1975
- Valcyte Valganciclovir Hydrochloride · 2009
- Pulmicort Flexhaler Budesonide · 2006
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.